Dorcas Kamuya
A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.Lucinde, R. K.
Gathuri, H.
Mwaniki, P.
Orindi, B.
Otieno, E. O.
Mwakio, S.
Mulemi, L.
Isaaka, L.
Shangala, J.
Saisi, M.
Isinde, E.
Oginga, I. N.
Wachira, A. W.
Manuthu, E.
Kariuki, H.
Asaava, P.
Nyikuli, J.
Wekesa, C.
Otedo, A.
Bosire, H.
Okoth, S. B.
Ongalo, W.
Mukabi, D. M.
Lusamba, W.
Muthui, B.
Adembesa, I.
Mithi, C.
Sood, M.
Aliyan, N. A.
Gituma, B.
Matiko, M. G.
Omondi, C. A.
Ombajo, L. A.
Kirui, N.
Ochola, L.
Abdi, A. I.
Kagucia, E. W.
English, M.
Hamaluba, M.
Ochola-Oyier, I.
Kamuya, D.
Bejon, P.
Barasa, E.
Agweyu, A.
Akech, S.
Etyang, A. O.
N Engl J Med, (2025). 393:2187-2197
A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA).Lucinde, R.
Abdi, A.
Orindi, B.
Mwakio, S.
Gathuri, H.
Onyango, E.
Chira, S.
Ogero, M.
Isaaka, L.
Shangala, J.
Oginga, I. N.
Wachira, A.
Manuthu, E.
Kariuki, H.
Nyikuli, J.
Wekesa, C.
Otedo, A.
Bosire, H.
Okoth, S. B.
Ongalo, W.
Mukabi, D.
Lusamba, W.
Muthui, B.
Kirui, N.
Adembesa, I.
Mithi, C.
Sood, M.
Ahmed, N.
Gituma, B.
Ongaki, V. B.
Giabe, M.
Omondi, C.
Ombajo, L. A.
Kagucia, W.
English, M.
Hamaluba, M.
Ochola-Oyier, L. I.
Kamuya, D.
Bejon, P.
Agweyu, A.
Akech, S.
Etyang, A. O.
Wellcome Open Res, (2025). 7:269
COVID-19 mortality in Africa and Asia - Authors' reply.Bejon, P.
Agweyu, A.
Oyier, I.
Hamaluba, M.
Kamuya, D.
Kinyanjui, S.
Barasa, E.
Lancet Infect Dis, (2025). 25:e440
Creating different global health futures: mapping the health research ecosystem and taking decolonial action.Tagoe, N.
Abimbola, S.
Bilardi, D.
Kamuya, D.
Gilson, L.
Muraya, K.
Molyneux, S.
Atuire, C.
BMC Health Serv Res, (2025). 25:565
Rethinking the evidence on COVID-19 in Africa.Bejon, P.
Agweyu, A.
Ochola-Oyier, L. I.
Hamaluba, M.
Kamuya, D.
Kinyanjui, S.
Barasa, E.
Lancet Infect Dis, (2025). 25:e463-e471
Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practice.Gobat, N.
Slack, C.
Hannah, S.
Salzwedel, J.
Bladon, G.
Burgos, J. G.
Purvis, B.
Molony-Oates, B.
Siegfried, N.
Cheah, P. Y.
Conway, M.
Kamuya, D.
Davies, A.
Johnson, T.
Tholanah, M.
Mugamba, S.
Mutengu, N. L.
Machingaidze, S.
Schwartz, L.
Rago, L.
von Harbou, K.
Lancet Glob Health, (2025). 13:e716-e731
Ethical preparedness of data monitoring committees (DMCs) to oversee international clinical trials: a qualitative descriptive study.Hinga, A.
Ibrahim, A.
Vintimilla, D.
Jones, M.
Eckstein, L.
Rid, A.
Shah, S. K.
Kamuya, D.
BMJ Glob Health, (2024). 9:
A scoping review of ethics review processes during public health emergencies in Africa.Orievulu, K.
Hinga, A.
Nkosi, B.
Ngwenya, N.
Seeley, J.
Akanlu, A.
Tindana, P.
Molyneux, S.
Kinyanjui, S.
Kamuya, D.
BMC Med Ethics, (2024). 25:63
Community engagement and the centrality of 'working relationships' in health research.Vincent, R.
Kamuya, D.
Adhikari, B.
Nyirenda, D.
Lavery, J. V.
Molyneux, S.
BMJ Glob Health, (2024). 9:
Ethical issues of involving people with intellectual disabilities in genomic research: a scoping review protocol.Chepkirui, D.
Kipkemoi, P.
Bitta, M.
Harris, E.
Musesengwa, R.
Kamuya, D.
Wellcome Open Res, (2023). 8:340
The hidden emotional labour behind ensuring the social value of research: Experiences of frontline health policy and systems researchers based in Kenya during COVID-19.Nzinga, J.
Oliwa, J.
Oluoch, D.
Jepkosgei, J.
Mbuthia, D.
Boga, M.
Musitia, P.
Ogola, M.
Muinga, N.
Muraya, K.
Hinga, A.
Kamuya, D.
Kelley, M.
Molyneux, S.
PLOS Glob Public Health, (2023). 3:e0002116
A network of empirical ethics teams embedded in research programmes across multiple sites: opportunities and challenges in contributing to COVID-19 research and responses.Ngwenya, N.
Ilo Van Nuil, J.
Nyirenda, D.
Chambers, M.
Cheah, P. Y.
Seeley, J.
Chi, P.
Mafuleka, L.
Nkosi, B.
Kamuya, D.
Davies, A.
Schneiders, M. L.
Mumba, N.
Dlamini, S.
Desmond, N.
Marsh, V.
Rippon, D.
Parker, M.
Molyneux, S.
Wellcome Open Res, (2023). 7:48
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.Odera, D. O.
Tuju, J.
Mwai, K.
Nkumama, I. N.
Furle, K.
Chege, T.
Kimathi, R.
Diehl, S.
Musasia, F. K.
Rosenkranz, M.
Njuguna, P.
Hamaluba, M.
Kapulu, M. C.
Frank, R.
Chmi-Sika Study Team
Osier, F. H. A.
Abdi, A. I.
Chi, P. C.
de Laurent, Z.
Jao, I.
Kamuya, D.
Kamuyu, G.
Makale, J.
Murungi, L.
Musyoki, J.
Muthui, M.
Mwacharo, J.
Kariuki, S.
Mwanga, D.
Mwongeli, J.
Ndungu, F.
Njue, M.
Nyangweso, G.
Kimani, D.
Ngoi, J. M.
Musembi, J.
Ngoto, O.
Otieno, E.
Ooko, M.
Shangala, J.
Wambua, J.
Mohammed, K. S.
Omuoyo, D.
Mosobo, M.
Kibinge, N.
Kinyanjui, S.
Bejon, P.
Lowe, B.
Marsh, K.
Marsh, V.
Abebe, Y.
Billingsley, P. F.
Sim, B. K. L.
Hoffman, S. L.
James, E. R.
Richie, T. L.
Audi, A.
Olewe, F.
Oloo, J.
Ongecha, J.
Ongas, M. O.
Koskei, N.
Bull, P. C.
Hodgson, S. H.
Kivisi, C.
Imwong, M.
Murphy, S. C.
Ogutu, B.
Tarning, J.
Winterberg, M.
Williams, T. N.
Sci Transl Med, (2023). 15:eabn5993
Rethinking benefit sharing in collaborative human genetic research from an Afrocommunitarian perspective.Ewuoso, C.
Sudoi, A.
Kamuya, D.
Front Genet, (2022). 13:1014120
Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt.Mumba, N.
Njuguna, P.
Chi, P.
Marsh, V.
Awuor, E.
Hamaluba, M.
Mauncho, C.
Mwalukore, S.
Masha, J.
Mwangoma, M.
Kalama, B.
Alphan, H.
Wambua, J.
Bejon, P.
Kamuya, D.
Kapulu, M. C.
Front Public Health, (2022). 10:793913
Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.Chi, P. C.
Owino, E. A.
Jao, I.
Bejon, P.
Kapulu, M.
Marsh, V.
Kamuya, D.
BMC Med Ethics, (2022). 23:46
Strengthening the Health System as a Strategy to Achieving a Universal Health Coverage in Underprivileged Communities in Africa: A Scoping Review.Jaca, A.
Malinga, T.
Iwu-Jaja, C. J.
Nnaji, C. A.
Okeibunor, J. C.
Kamuya, D.
Wiysonge, C. S.
Int J Environ Res Public Health, (2022). 19:
A scoping review of considerations and practices for benefit sharing in biobanking.Sudoi, A.
De Vries, J.
Kamuya, D.
BMC Med Ethics, (2021). 22:102
Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders.Chi, P. C.
Owino, E. A.
Jao, I.
Olewe, F.
Ogutu, B.
Bejon, P.
Kapulu, M.
Kamuya, D.
Marsh, V.
Chmi-Sika Study Team
Trials, (2021). 22:494
Always leave the audience wanting more: An entertaining approach to stimulate engagement with health research among publics in coastal Kenya through 'Magnet Theatre'.Sanga, G.
Jao, I.
Mumba, N.
Mwalukore, S.
Kamuya, D.
Davies, A.
Wellcome Open Res, (2021). 6:2